(May 14, 2018, 1:34 PM EDT) -- CHARLESTON, W.Va. — The West Virginia Supreme Court of Appeals on May 11 ruled that state statutory law, case law, public policy and legal precedent do not allow the manufacturer of the antibiotic Levaquin to be sued for injuries allegedly caused by the drug’s generic version, levofloxacin (Kimmy McNair, et al. v. Johnson & Johnson, et al., No. 17-0519, W.Va. Sup. Ct. App., 2018 W.Va. LEXIS 344)....